LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (AMEX:SLP), a leading provider of software for pharmaceutical discovery and development, today announced that F. Hoffmann-LaRoche (“Roche”) (NYSE:RHHBY) has renewed and expanded its global licenses for Simulations Plus software for another two years.
